CADL
Price
$4.42
Change
-$0.20 (-4.33%)
Updated
Nov 19 closing price
Capitalization
253.63M
126 days until earnings call
Intraday BUY SELL Signals
RNAC
Price
$7.15
Change
-$0.47 (-6.17%)
Updated
Nov 19 closing price
Capitalization
186.84M
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs RNAC

Header iconCADL vs RNAC Comparison
Open Charts CADL vs RNACBanner chart's image
Candel Therapeutics
Price$4.42
Change-$0.20 (-4.33%)
Volume$518.7K
Capitalization253.63M
Cartesian Therapeutics
Price$7.15
Change-$0.47 (-6.17%)
Volume$101.81K
Capitalization186.84M
CADL vs RNAC Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
RNAC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. RNAC commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CADL: $4.42 vs. RNAC: $7.18)
Brand notoriety: CADL and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 69% vs. RNAC: 87%
Market capitalization -- CADL: $253.63M vs. RNAC: $186.84M
CADL [@Biotechnology] is valued at $253.63M. RNAC’s [@Biotechnology] market capitalization is $186.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 1 green, 4 red.
According to our system of comparison, RNAC is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 6 bearish.
  • RNAC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а -10.16% price change this week, while RNAC (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($254M) has a higher market cap than RNAC($187M). CADL YTD gains are higher at: -49.078 vs. RNAC (-59.883). CADL has higher annual earnings (EBITDA): -19.74M vs. RNAC (-118.73M). RNAC has more cash in the bank: 160M vs. CADL (101M). CADL has less debt than RNAC: CADL (8.34M) vs RNAC (13.3M). RNAC has higher revenues than CADL: RNAC (1.03M) vs CADL (0).
CADLRNACCADL / RNAC
Capitalization254M187M136%
EBITDA-19.74M-118.73M17%
Gain YTD-49.078-59.88382%
P/E RatioN/A1.98-
Revenue01.03M-
Total Cash101M160M63%
Total Debt8.34M13.3M63%
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLRNAC
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
RNAC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCXF0.08N/A
N/A
ArcelorMittal South Africa
DISPF291.25N/A
N/A
Disco Corp.
YZCFF0.07N/A
N/A
Sinopec Yizheng Chem Fibre Co Ltd
PDIYF0.37N/A
N/A
Predictive Discovery Ltd.
TROYF0.08N/A
N/A
TROY MINERALS INC.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-4.33%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
42%
Loosely correlated
-3.36%
MDGL - CADL
33%
Poorly correlated
-0.61%
RNAC - CADL
32%
Poorly correlated
-5.71%
INO - CADL
32%
Poorly correlated
-5.82%
More